Apo-Famotidine · DIN 01953834 · 40 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2024-07-21 — choose a marketed DIN from the same-category list.Discontinued July 21, 2024 · checked November 18, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2024-07-21 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2024-07-21 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Apo-Famotidine · DIN 01953834
Manufacturer: Apotex Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2024-07-21 · brand APO-FAMOTIDINE TAB 40MG USP · ATC A02BA03 FAMOTIDINE · form Tablet · route Oral · ingredients FAMOTIDINE 40 MG · company Apotex inc · schedule Prescription
Apo-Famotidine: Formulary list price $0.48 per unit (the source does not state the unit; exact figure $0.4834). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01953834)
Source record
DIN 01953834: Apo-Famotidine
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000024; group id 678; item number 1694; lccId None; manufacturer id APX
Source form: Tab; strength: 40mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.4834; ministry $0.4834
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01953834
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13583
Interchangeable products
AG-Famotidine · DIN 02509989 · $0.4834
Famotidine · DIN 02351110 · $0.4834
Famotidine · DIN 02549115 · $0.4834
Jamp Famotidine · DIN 02507757 · $0.4834
Mint-Famotidine · DIN 02538636 · $0.4834
Pepcid · DIN 00710113 · not recorded
Teva-Famotidine · DIN 02022141 · $0.4834
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since July 21, 2024 — choose a marketed DIN from the same-category list.